Cardiovascular Outcomes During 6.8 Years of Hormone Therapy: Heart and Estrogen/Progestin Replacement Study Follow-Up (HERS II)
Obstetrical & Gynecological SurveyPublished 1 October 2002
Deborah Grady, David Herrington, Vera Bittner, Roger S. Blumenthal, Michael H. Davidson, Mark A. Hlatky
Citations124
SJR quartileQ2
SJR score0.57
SNIP1.41
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The findings suggest that hormone therapy not be used to lower the risk of cardiovascular events in postmenopausal women with coronary disease.
Abstract
Grady, Deborah; Herrington, David; Bittner, Vera; Blumenthal, Roger; Davidson, Michael; Hlatky, Mark; Hsia, Judith; Hulley, Stephen; Herd, Alan; Khan, Steven; Newby, L. Kristin; Waters, David; Vittinghoff, Eric; Wenger, Nanette for the HERS Research Group
Keywords
MedicineBiochemistry, Genetics and Molecular Biology